| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/18/1996 | WO1996021436A1 Improved therapeutic compositions comprising bactericidal/permeability-increasing (bpi) protein products |
| 07/18/1996 | WO1996021435A1 Compounds for and method of inhibiting phosphodiesterase iv |
| 07/18/1996 | WO1996021416A2 Methods and compositions for treatment of solid tumors in vivo |
| 07/18/1996 | WO1996003122A3 Use of gabapentin in the treatment of anxiety and panic |
| 07/18/1996 | WO1996001253A3 PLA2 inhibitors and their use for inhibition of intestinal cholesterol absorption |
| 07/18/1996 | WO1995033062A3 Method for introducing foreign matter into higher eukaryotic cells |
| 07/18/1996 | CA2210390A1 Improved therapeutic compositions comprising bactericidal/permeability-increasing (bpi) protein products |
| 07/18/1996 | CA2210322A1 Novel compounds |
| 07/18/1996 | CA2209938A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 07/18/1996 | CA2209936A1 Indole derivatives useful in the treatment of osteoporosis |
| 07/18/1996 | CA2209895A1 Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents |
| 07/18/1996 | CA2209557A1 Chemically modified interferon |
| 07/18/1996 | CA2209125A1 Compounds for and method of inhibiting phosphodiesterase iv |
| 07/18/1996 | CA2207252A1 Inhibitors of prenyl transferases |
| 07/17/1996 | EP0721955A2 Diadenosine tetraphosphate tetrasodium salt dodecahydrate crystals |
| 07/17/1996 | EP0721950A2 Cardioactive 3-alkoxycarbonyl-thiadiazinones |
| 07/17/1996 | EP0721947A1 Alkyl(hetero)cyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/17/1996 | EP0721938A1 Alkyl(hetero)cyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/17/1996 | EP0721778A2 NK-1 receptor antagonists for the treatment of neuronal injury and stroke |
| 07/17/1996 | EP0721501A1 Pharmaceutical composition comprising phosphatase or a derivative thereof |
| 07/17/1996 | EP0721465A1 Glutathione s-transferase-activated compounds |
| 07/17/1996 | EP0721464A1 Neuron regulatory factor for promoting neuron survival |
| 07/17/1996 | EP0721463A1 Endothelial monocyte activating polypeptide ii: a mediator which activates host response |
| 07/17/1996 | EP0721455A1 Tetrahydropyridine-(or 4-hydroxypiperidine)alkylazoles having an affinity for sigma and/or 5ht1a receptors |
| 07/17/1996 | EP0721330A1 Pharmaceutical composition |
| 07/17/1996 | EP0441900B1 Natural killer stimulatory factor |
| 07/17/1996 | CN1126947A Use of lignan derivatives for the preparation of pharmaceutical compositions for the treatment of states of amyloidosis |
| 07/17/1996 | CN1126727A 11,21-bisphenyl-19-norpregnane derivatives |
| 07/17/1996 | CN1126720A Heterocyclo-benzoylguanidin |
| 07/17/1996 | CN1126590A Pharmaceutical compositions and a process for the preparation thereof |
| 07/17/1996 | CN1032309C 吲哚衍生物 Indole derivatives |
| 07/17/1996 | CN1032308C Process for preparing optically active 2-oxoimidazolidine derivatives |
| 07/16/1996 | US5536828 (E)-20 (22)-dehydrodiels-alder compounds |
| 07/16/1996 | US5536812 Calcitonin analogue and use thereof |
| 07/16/1996 | US5536752 Phenyl heterocycles as COX-2 inhibitors |
| 07/16/1996 | US5536740 Skin care compositions containing dimethyl imidazolidinone and retinol or retinyl ester |
| 07/16/1996 | US5536736 Triazolyl-phenoxyacetic acid compounds which have useful pharmaceutical utility |
| 07/16/1996 | US5536719 Nervous system disorders |
| 07/16/1996 | US5536713 Osteoporosis |
| 07/16/1996 | US5536709 2(1H)-quinolone compounds |
| 07/16/1996 | US5536641 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1 and uses thereof for detection of, and isolation of, vascular endothelial cells |
| 07/13/1996 | CA2166958A1 Indolepiperidine derivatives |
| 07/12/1996 | CA2166854A1 3-alkoxycarbonyl-thiadiazinones |
| 07/11/1996 | WO1996021014A2 Production and administration of high titer recombinant retroviruses |
| 07/11/1996 | WO1996020958A1 Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples |
| 07/11/1996 | WO1996020956A1 Anti-inflammatory cd14 peptides |
| 07/11/1996 | WO1996020936A1 Novel thiazolidin-4-one derivatives |
| 07/11/1996 | WO1996020926A1 Substituted imides as tnf inhibitors |
| 07/11/1996 | WO1996020918A1 Hydroxamic acid-containing inhibitors of matrix metalloproteases |
| 07/11/1996 | WO1996020915A1 Novel immunotherapeutic aryl amides |
| 07/11/1996 | WO1996020914A1 Tricyclic retinoids, methods for their production and use |
| 07/11/1996 | WO1996020913A1 Novel trienoic retinoid compounds and methods |
| 07/11/1996 | WO1996020728A1 Antitumor agent potentiator comprising il-6 antagonist |
| 07/11/1996 | WO1996020727A1 Chicken anaemia agent broiler vaccine |
| 07/11/1996 | WO1996020723A1 Controlling traf-mediated signals |
| 07/11/1996 | WO1996020721A1 Programmed cell death genes and proteins |
| 07/11/1996 | WO1996020718A2 Composition for inhibiting intimal hyperplasia using pdgf antagonists and heparin |
| 07/11/1996 | WO1996020710A1 Compounds for inhibition of ceramide-mediated signal transduction |
| 07/11/1996 | WO1996020705A1 IMMUNOTHERAPEUTIC IMIDES/AMIDES AND THEIR USE FOR REDUCING LEVELS OF TNF$g(a) |
| 07/11/1996 | WO1996020704A1 Treating disorders characterised by excessive cell proliferation with sclareolide |
| 07/11/1996 | WO1996020703A1 Compounds for veterinary and medicinal applications |
| 07/11/1996 | WO1996020701A1 Apoptosis-modulating composition comprising a factor affecting the intracellular rate of methional or malondialdehyde |
| 07/11/1996 | WO1996020690A2 3,3-(disubstituted)cyclohexan-1-ylidine acetate monomers and related compounds |
| 07/11/1996 | WO1996015128A3 6-ARYL PYRIDO[2,3-d]PYRIMIDINES AND NAPHTHYRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION |
| 07/11/1996 | CA2209526A1 Programmed cell death genes and proteins |
| 07/11/1996 | CA2209276A1 Treating disorders characterised by excessive cell proliferation with sclareolide |
| 07/11/1996 | CA2209134A1 Tricyclic retinoids, methods for their production and use |
| 07/11/1996 | CA2208679A1 Hydroxamic acid-containing inhibitors of matrix metalloproteases |
| 07/11/1996 | CA2208580A1 Compounds for inhibition of ceramide-mediated signal transduction |
| 07/11/1996 | CA2208411A1 Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples |
| 07/11/1996 | CA2208016A1 Anti-inflammatory cd14 peptides |
| 07/11/1996 | CA2184174A1 Novel thiazolidin-4-one derivatives |
| 07/10/1996 | EP0720857A1 Syringe |
| 07/10/1996 | EP0720855A2 Composition for the treatment of hypertension comprising non halide salts of potassium |
| 07/10/1996 | EP0720620A1 Glutathione analogs and paralog panels comprising glutathione mimics |
| 07/10/1996 | EP0720609A1 3-(5-tetrazolyl-benzyl)amino-piperidine derivatives and antagonists of tachykinins |
| 07/10/1996 | EP0720603A1 Bis(amidinobenzimidazolyl)alkanes as antiviral agents |
| 07/10/1996 | EP0720601A1 Gastrin and cck receptor ligands |
| 07/10/1996 | EP0720600A1 3-(3,4-dioxyphenyl)-pyrrolidines as type iv phosphodiesterase inhibitors for the treatment of inflammatory diseases |
| 07/10/1996 | EP0720598A1 Phenoxyphenyl cyclopentenyl hydroxyureas |
| 07/10/1996 | EP0720551A1 Hydraulic system for anti-lock braking installations in motor vehicles |
| 07/10/1996 | EP0720482A1 Prosaposin and cytokine-derived peptides as therapeutic agents |
| 07/10/1996 | EP0720480A1 Enteric coated oral compositions containing bisphosphonic acid derivatives |
| 07/10/1996 | EP0720477A1 Method and compositions for maintaining glomerular filtration rate while inhibition extracellular matrix accumulation |
| 07/10/1996 | EP0710267A4 Storage stable partially neutralized acid compositions and uses |
| 07/10/1996 | CN1126472A 5-HT4 receptor antagonists |
| 07/10/1996 | CN1126468A Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors |
| 07/10/1996 | CN1126438A Method of combating acyclovir-resistant herpes simplex viral infections |
| 07/10/1996 | CN1126434A Therapeutic substituted guanidines |
| 07/10/1996 | CN1126207A Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-one derivatives, process for their preparation and the pharmaceutical compositions containing them |
| 07/10/1996 | CN1126203A Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals |
| 07/10/1996 | CN1126092A Selenium-riched Chinese caterpillar fungus oral liquor and its prepn. method |
| 07/10/1996 | CN1032253C Process for preparation of oxalylamino acid derivatives, and their use as medicaments for inhibiting proline hydroxylase |
| 07/09/1996 | US5534533 Carboxylate derivatives exhibiting phospholipase A2 inhibitory activity |
| 07/09/1996 | US5534530 5-acylamino-1,2,4-thiadiazoles, their preparation and pharmaceutical compositions containing them |
| 07/09/1996 | US5534529 Substituted aromatic amides and ureas derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses |
| 07/09/1996 | US5534528 Thiadiazolyl tetrhydrpyridines for treating glaucoma |
| 07/09/1996 | US5534527 Treatment of osteoporosis |
| 07/09/1996 | US5534525 Lactam derivatives |
| 07/09/1996 | US5534517 (Aryl(alkyl)carbonyl)-heterocyclic compounds and their use in the treatment of anxiety and depression |